NCT00409656View on ClinicalTrials.gov

Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2003

Study Completion Date

December 31, 2005

Conditions
Corneal Transplantation
Interventions
DRUG

Basiliximab

All Listed Sponsors
lead

University Hospital Freiburg

OTHER

NCT00409656 - Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty Patients | Biotech Hunter | Biotech Hunter